10x Genomics TXG
NASDAQ TXG
$93.59 +3.55 (+3.94%)
As of: Sep 30, 2026 · 11:44 AM EDT

10x Genomics (TXG) Short term Debt (2018 - 2019)

Updated

10x Genomics (TXG) reported Short term Debt of $9.88 million for Q4 2019, up 136.0% from $4.19 million a year earlier and up 33.8% from the prior quarter.

Analysis

10x Genomics (TXG) Short term Debt (2018 - 2019) Analysis & Trends

  • By year, Short term Debt came in at $4.19 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 10x Genomics 11.53 Bn 11.33 Bn 112.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 9.88 Mn
Sep 30, 2019 7.38 Mn
Dec 31, 2018 4.19 Mn
API Access

10x Genomics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TXG&period=max&api_key=YOUR_API_KEY